Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques. - Archive ouverte HAL Access content directly
Journal Articles Journal of Virology Year : 2010

Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques.

(1) , (1) , (1) , (1) , (2) , (3) , (1) , (1) , (1) , (4) , (5) , (6) , (6) , (7) , (2) , (3, 8) , (9) , (10) , (4) , (1)
1
2
3
4
5
6
7
8
9
10
Zhong-Min Ma
  • Function : Author
Jean-Michel Heraud
Renaud Mahieux
  • Function : Author

Abstract

Coinfection with human T-cell lymphotropic virus type 2 (HTLV-2) and human immunodeficiency virus type 1 (HIV-1) has been reported to have either a slowed disease course or to have no effect on progression to AIDS. In this study, we generated a coinfection animal model and investigated whether HTLV-2 could persistently infect macaques, induce a T-cell response, and impact simian immunodeficiency virus SIV(mac251)-induced disease. We found that inoculation of irradiated HTLV-2-infected T cells into Indian rhesus macaques elicited humoral and T-cell responses to HTLV-2 antigens at both systemic and mucosal sites. Low levels of HTLV-2 provirus DNA were detected in the blood, lymphoid tissues, and gastrointestinal tracts of infected animals. Exposure of HTLV-2-infected or naïve macaques to SIV(mac251) demonstrated comparable levels of SIV(mac251) viral replication, similar rates of mucosal and peripheral CD4(+) T-cell loss, and increased T-cell proliferation. Additionally, neither the magnitude nor the functional capacity of the SIV-specific T-cell-mediated immune response was different in HTLV-2/SIV(mac251) coinfected animals versus SIV(mac251) singly infected controls. Thus, HTLV-2 targets mucosal sites, persists, and importantly does not exacerbate SIV(mac251) infection. These data provide the impetus for the development of an attenuated HTLV-2-based vectored vaccine for HIV-1; this approach could elicit persistent mucosal immunity that may prevent HIV-1/SIV(mac251) infection.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

pasteur-00589395 , version 1 (28-04-2011)

Identifiers

Cite

Shari N Gordon, Anna R Weissman, Valentina Cecchinato, Claudio Fenizia, Zhong-Min Ma, et al.. Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques.. Journal of Virology, 2010, 84 (6), pp.3043-58. ⟨10.1128/JVI.01655-09⟩. ⟨pasteur-00589395⟩
72 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More